DS
Doug Schenkel Wolfe Research Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
|
CAI
1
Caris Life Sciences, Inc. Common Stock
CAI
$10.4B
| $36.35 | $32 |
12%
downside
| Outperform | 1 month ago |
|
|
TEM
2
Tempus AI, Inc. Class A Common Stock
TEM
$13.6B
| $78.12 | $60 |
23%
downside
| Outperform | 8 months ago |
|
3
Twist Bioscience
TWST
$1.55B
| $25.63 | $60 |
134%
upside
| Outperform | 8 months ago |
|
4
Stevanato
STVN
$6.29B
| $23.04 | $28 |
22%
upside
| Outperform | 8 months ago |
|
5
Danaher
DHR
$143B
| $199.03 | $285 |
43%
upside
| Outperform | 10 months ago |
|
6
Qiagen
QGEN
$10.2B
| $47.04 | $51.50 |
9%
upside
| Outperform | 1 year ago |
|
7
Thermo Fisher Scientific
TMO
$185B
| $489.49 | $655 |
34%
upside
| Outperform | 4 years ago |
|
8
Agilent Technologies
A
$36.4B
| $128.48 | $200 |
56%
upside
| Outperform | 4 years ago |
|
9
Guardant Health
GH
$7.65B
| $61.36 | $190 |
210%
upside
| Outperform | 4 years ago |
|
10
10x Genomics
TXG
$1.69B
| $13.57 | $200 |
1,374%
upside
| Outperform | 4 years ago |
|
11
Exact Sciences
EXAS
$9.73B
| $51.41 | $180 |
250%
upside
| Outperform | 4 years ago |
|
12
Hologic
HOLX
$14.8B
| $66.39 | $64 |
4%
downside
| Outperform | 5 years ago |
|
13
Natera
NTRA
$22.9B
| $166.56 | $40 |
76%
downside
| Outperform | 5 years ago |
|